Seward Rutkove’s lab focuses on a broad range of neuromuscular disorders, including:

  • amyotrophic lateral sclerosis: recent novel study is the ALS Testing through Home-Based Outcome Measures (ALS AT HOME). To learn more, please visit:  www.ALS-AT-HOME.org

 

  • muscular dystrophy
  • spinal muscular atrophy
  • polyneuropathies, including diabetic neuropathy
  • inflammatory myopathies
  • radiculopathy
  • localized nerve problems/compressions

 

 

hg

Much of our research involves the application of electrophysiological measures, imaging modalities, and innovative bioengineering approaches to diagnose and treat these disorders.  These techniques include electrical impedance myography, quantitative ultrasound, magnetic resonance imaging, and nerve and muscle excitability techniques. We are also interested in studying mechanisms of disease pathogenesis and testing new therapeutic agents that can improve function and health. Some of our longer term goals include developing novel, powerful biomarkers to assist with disease diagnosis, the assessment of progression, and the effect of therapy.

 

We invite you to explore our publications to learn more about our research efforts.

 

Seward Rutlove’s Lab has received funding from a variety sources over the past decade, including NIH, the SMA Foundation, the ALS Association, and NASA. 

                              622screen-shot-2016-10-25-at-12-00-11-pm3

 

 

 

5screen-shot-2016-10-25-at-12-01-44-pm          screen-shot-2016-10-25-at-12-03-35-pm10

 

 

 

11screen-shot-2016-10-25-at-12-05-52-pm7screen-shot-2016-10-25-at-12-06-37-pm

 

 

 

 

 

 

 

 

 

.

.

.